WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering,...

WeightWatchers Announces Executive Leadership Transition Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International,...

WeightWatchers Announces Strategic Leadership Team Appointments NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today the appointments of Scott Honken as Chief Commercial Officer and...